Mattias Trau - Nanotechnology

Author Information

Mattias Trau is a distinguished researcher affiliated with the Centre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD, 4072, Australia. His work primarily focuses on nanotechnology and its applications in personalized medicine, particularly in the domains of cancer diagnostics and therapeutics.

Research Contributions

Mattias Trau has made significant contributions to the field of nanotechnology and personalized medicine. His recent works include advancements in cancer biomarker detection, such as the development of electrochemical and Raman scattering dual detection biosensors for rapid screening and profiling of cancer biomarkers. He has also contributed to the understanding of molecular mechanisms in diseases like Barrett’s Esophagus and Esophageal Adenocarcinoma, and has innovated techniques in ctDNA methylation-based pan-cancer screening technologies. His research extends to metabolic engineering, SARS-CoV-2 detection, single-cell proteomics, and nanoparticle behavior, showcasing his diverse expertise and impact in the field.

Aliases

Mattias Trau is also known by several aliases including M Trau, M. Trau, and Matt Trau.

Publication and Citation Metrics

Metric Value
Total Citations 8550
H-Index 52
Total Publications 291

Publications:

DOI: 10.1007/978-1-0716-1799-1_11

Year: 2022

DOI: 10.1021/acs.langmuir.0c03083

Year: 2021

Partnered Content Networks

Relevant Topics